Current approaches specifically target cytokines (e.g., BLyS), intracellular pathways (e.g., calcineurin) as well as cell populations (e.g., B cells) according to the advances in our understanding of the pathogenesis of SLE. Here, TNFSF13B is linked to systemic lupus erythematosus.